158 related articles for article (PubMed ID: 31464215)
1. Pidotimod: In-depth review of current evidence.
Mahashur A; Thomas PK; Mehta P; Nivangune K; Muchhala S; Jain R
Lung India; 2019; 36(5):422-433. PubMed ID: 31464215
[TBL] [Abstract][Full Text] [Related]
2. Immunostimulants in respiratory diseases: focus on Pidotimod.
Puggioni F; Alves-Correia M; Mohamed MF; Stomeo N; Mager R; Marinoni M; Racca F; Paoletti G; Varricchi G; Giorgis V; Melioli G; Canonica GW; Heffler E
Multidiscip Respir Med; 2019; 14():31. PubMed ID: 31700623
[TBL] [Abstract][Full Text] [Related]
3. Pidotimod may prevent recurrent respiratory infections in children.
Licari A; De Amici M; Nigrisoli S; Marseglia A; Caimmi S; Artusio L; Marseglia GL
Minerva Pediatr; 2014 Oct; 66(5):363-7. PubMed ID: 25253184
[TBL] [Abstract][Full Text] [Related]
4. Pidotimod for the prevention of acute respiratory infections in healthy children entering into daycare: A double blind randomized placebo-controlled study.
Mameli C; Pasinato A; Picca M; Bedogni G; Pisanelli S; Zuccotti GV;
Pharmacol Res; 2015 Jul; 97():79-83. PubMed ID: 25931316
[TBL] [Abstract][Full Text] [Related]
5. Pidotimod: the state of art.
Ferrario BE; Garuti S; Braido F; Canonica GW
Clin Mol Allergy; 2015; 13(1):8. PubMed ID: 25999796
[TBL] [Abstract][Full Text] [Related]
6. Expert Opinion on Usage of Pidotimod in Adult Patients with Chronic Obstructive Pulmonary Disease: An Indian Perspective.
Mahashur A; Vora A; Waghray P; Jafrey SZ; Karadkhele A; Muchhala S; Rathod R; Suvarna V
J Assoc Physicians India; 2021 Sep; 69(9):11-12. PubMed ID: 34585899
[TBL] [Abstract][Full Text] [Related]
7. Pidotimod in the management of recurrent pharyngotonsillar infections in childhood.
Passali D; Calearo C; Conticello S
Arzneimittelforschung; 1994 Dec; 44(12A):1511-6. PubMed ID: 7857354
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the efficacy of pidotimod in the exacerbations in patients affected with chronic bronchitis.
Bisetti A; Ciappi G; Bariffi F; Catena E; Rocco V; Vaccaro L; Grassi V; Scarpazza G; Bertoli L; Cardani A
Arzneimittelforschung; 1994 Dec; 44(12A):1499-502. PubMed ID: 7857351
[TBL] [Abstract][Full Text] [Related]
9. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
Teo E; House H; Lockhart K; Purchuri SN; Pushparajah J; Cripps AW; van Driel ML
Cochrane Database Syst Rev; 2014 Sep; (9):CD010010. PubMed ID: 25201571
[TBL] [Abstract][Full Text] [Related]
10. Prophylaxis with the novel immunomodulator pidotimod reduces the frequency and severity of upper respiratory tract infections in children with Down's syndrome.
La Mantia I; Grillo C; Mattina T; Zaccone P; Xiang M; Di Mauro M; Meroni PL; Nicoletti F
J Chemother; 1999 Apr; 11(2):126-30. PubMed ID: 10326743
[TBL] [Abstract][Full Text] [Related]
11. Effects of pidotimod and bifidobacteria mixture on clinical symptoms and urinary metabolomic profile of children with recurrent respiratory infections: a randomized placebo-controlled trial.
Santamaria F; Montella S; Stocchero M; Pirillo P; Bozzetto S; Giordano G; Poeta M; Baraldi E
Pulm Pharmacol Ther; 2019 Oct; 58():101818. PubMed ID: 31302340
[TBL] [Abstract][Full Text] [Related]
12. Pidotimod, an immunostimulant in pediatric recurrent respiratory tract infections: A meta-analysis of randomized controlled trials.
Niu H; Wang R; Jia YT; Cai Y
Int Immunopharmacol; 2019 Feb; 67():35-45. PubMed ID: 30530167
[TBL] [Abstract][Full Text] [Related]
13. Metabolomic profile of children with recurrent respiratory infections.
Bozzetto S; Pirillo P; Carraro S; Berardi M; Cesca L; Stocchero M; Giordano G; Zanconato S; Baraldi E
Pharmacol Res; 2017 Jan; 115():162-167. PubMed ID: 27888158
[TBL] [Abstract][Full Text] [Related]
14. Pidotimod in the treatment of recurrent respiratory infections in paediatric patients.
Careddu P; Mei V; Venturoli V; Corsini A
Arzneimittelforschung; 1994 Dec; 44(12A):1485-9. PubMed ID: 7857348
[TBL] [Abstract][Full Text] [Related]
15. [Comparative meta-analysis of immunoestimulant agents used in pediatric patients in Mexico].
de la Torre González C; Pacheco Ríos A; Escalante Domínguez AJ; del Río Navarro BE
Rev Alerg Mex; 2005; 52(1):25-38. PubMed ID: 15957470
[TBL] [Abstract][Full Text] [Related]
16. Immunoactivity of pidotimod against episodes of recurrent tonsillitis in childhood.
Motta G; De Campora E; De Vita C; Esposito S; Galletti C; Incutti V; Mallardi V; Motta S; Pucci V; Salonna F
Arzneimittelforschung; 1994 Dec; 44(12A):1521-4. PubMed ID: 7857356
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of pidotimod in the treatment of recurrent respiratory infections in children.
Caramia G; Clemente E; Solli R; Mei V; Cera R; Carnelli V; Venturoli V; Corsini A
Arzneimittelforschung; 1994 Dec; 44(12A):1480-4. PubMed ID: 7857347
[TBL] [Abstract][Full Text] [Related]
18. Pidotimod: a review of its pharmacological features and clinical effectiveness in respiratory tract infections.
Zhao N; Liu C; Zhu C; Dong X; Liu X
Expert Rev Anti Infect Ther; 2019 Oct; 17(10):803-818. PubMed ID: 31603361
[No Abstract] [Full Text] [Related]
19. [Pidotimod in recurring respiratory infection in children with allergic rhinitis, asthma, or both conditions].
Vargas Correa JB; Espinosa Morales S; Bolaños Ancona JC; Farfán Ale JA
Rev Alerg Mex; 2002; 49(2):27-32. PubMed ID: 12092522
[TBL] [Abstract][Full Text] [Related]
20. Pidotimod activity against chronic bronchitis exacerbations.
Ciaccia A
Arzneimittelforschung; 1994 Dec; 44(12A):1516-20. PubMed ID: 7857355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
